Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Lucie Bartova, Markus Dold, Alexander Kautzky, Chiara Fabbri, Marie Spies, Alessandro Serretti, Daniel Souery, Julien Mendlewicz, Joseph Zohar, Stuart Montgomery, Alexandra Schosser & Siegfried Kasper. (2019) Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice. The World Journal of Biological Psychiatry 20:6, pages 427-448.
Read now
Read now
Andreas Menke. (2013) Gene expression: Biomarker of antidepressant therapy?. International Review of Psychiatry 25:5, pages 579-591.
Read now
Read now
Pothitos M Pitychoutis, Nikolaos Kokras, Despina Sanoudou, Christina Dalla & Zeta Papadopoulou-Daifoti. (2013) Pharmacogenetic considerations for late life depression therapy. Expert Opinion on Drug Metabolism & Toxicology 9:8, pages 989-999.
Read now
Read now
Michael Bauer, Andrea Pfennig, Emanuel Severus, Peter C. Whybrow, Jules Angst & Hans-Jürgen Möller. (2013) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders. The World Journal of Biological Psychiatry 14:5, pages 334-385.
Read now
Read now
Oliver G. Bosch, Erich Seifritz & Thomas C. Wetter. (2012) Stress-related depression: Neuroendocrine, genetic, and therapeutical aspects. The World Journal of Biological Psychiatry 13:8, pages 556-568.
Read now
Read now
Ulrich-Michael Hemmeter, Julia Hemmeter-Spernal & Jürgen-Christian Krieg. (2010) Sleep deprivation in depression. Expert Review of Neurotherapeutics 10:7, pages 1101-1115.
Read now
Read now
Falk W Lohoff & Thomas N Ferraro. (2010) Pharmacogenetic considerations in the treatment of psychiatric disorders. Expert Opinion on Pharmacotherapy 11:3, pages 423-439.
Read now
Read now
Alison A Motsinger, Marylyn D Ritchie & Seth E Dobrin. (2006) Clinical applications of whole-genome association studies: future applications at the bedside. Expert Review of Molecular Diagnostics 6:4, pages 551-565.
Read now
Read now
Fabrice Duval, Barry D. Lebowitz & Jean-Paul Macher. (2006) Treatments in depression. Dialogues in Clinical Neuroscience 8:2, pages 191-206.
Read now
Read now
Articles from other publishers (75)
Chinonyelum E. AgboUzochukwu E. ChimaChukwuemeka A. NwachuyaNdikpongkeabasi V. EnangChristabel O. OkoyeSylvia M. MbajiNgozi M. UzokweAmauche P. NgigeOtito F. IwuchukwuAndrea Okoloekwe. (2023) The psychological impact of non-responsiveness to antidepressants on patients with depression and the role of pharmacogenomics-based drug therapy. American Journal of Pharmacotherapy and Pharmaceutical Sciences 2, pages 14.
Crossref
Crossref
Abiza Wali, Mashooq Ahmad Dar, Aarif Ali, Iyman Rasool, Lubna Tariq, Azher Arafah, Muneeb U. Rehman, Bashir Ahmad Malla & Adil Farooq Wali. 2023. Pharmacogenomics. Pharmacogenomics
169
194
.
Wen-cong Zhou, Lin Jia, Qi Deng, Yu-guan Wen, De-wei Shang, Xiao-jia Ni, Yao-xing Huang, Yao Liu, Han-bing Zhao, Meng Yang & Guo-yuan Dou. (2021) Role of serum amitriptyline concentration and CYP2C19 polymorphism in predicting the response to low-dose amitriptyline in irritable bowel syndrome. Digestive and Liver Disease 53:11, pages 1422-1427.
Crossref
Crossref
Vincenzo Oliva, Matteo Lippi, Riccardo Paci, Lorenzo Del Fabro, Giuseppe Delvecchio, Paolo Brambilla, Diana De Ronchi, Giuseppe Fanelli & Alessandro Serretti. (2021) Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 109, pages 110266.
Crossref
Crossref
Donatella Marazziti, Federico Mucci, Maria T. Avella, Laura Palagini, Marly Simoncini & Liliana Dell’Osso. (2020) The increasing challenge of the possible impact of ethnicity on psychopharmacology. CNS Spectrums 26:3, pages 222-231.
Crossref
Crossref
Farhana Islam, Ilona Gorbovskaya & Daniel J. Müller. 2021. Major Depressive Disorder. Major Depressive Disorder
231
255
.
Juncai Xin, Meng Yuan, Yonglin Peng & Ju Wang. (2020) Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder. Frontiers in Psychiatry 11.
Crossref
Crossref
Jose Alfonso Ontiveros. 2019. Antidepressants - Preclinical, Clinical and Translational Aspects. Antidepressants - Preclinical, Clinical and Translational Aspects.
Dorothy Keine. (2019) Depression-inducing drugs and the frequency of depression in Alzheimer’s disease and APOE ε4 carriers. F1000Research 8, pages 1782.
Crossref
Crossref
Lanxiang Liu, Xinyu Zhou, Yuqing Zhang, Juncai Pu, Lining Yang, Shuai Yuan, Libo Zhao, Chanjun Zhou, Hanping Zhang & Peng Xie. (2018) Hippocampal metabolic differences implicate distinctions between physical and psychological stress in four rat models of depression. Translational Psychiatry 8:1.
Crossref
Crossref
Jesús‐Servando Medel‐MatusDon ShinRaman SankarAndrey Mazarati. (2017) Inherent vulnerabilities in monoaminergic pathways predict the emergence of depressive impairments in an animal model of chronic epilepsy. Epilepsia 58:8.
Crossref
Crossref
Henrik Thyge Corfitsen & Antonio Drago. (2017) Insight gained from genome-wide interaction and enrichment analysis on weight gain during citalopram treatment. Neuroscience Letters 637, pages 38-43.
Crossref
Crossref
Sai Krishna J. Munjampalli & Debra E. Davis. (2016) Medicinal-Induced Behavior Disorders. Neurologic Clinics 34:1, pages 133-169.
Crossref
Crossref
Frédérique Rodieux, Valérie Piguet, Patricia Berney, Jules Desmeules & Marie Besson. (2015) Pharmacogenetics and analgesic effects of antidepressants in chronic pain management. Personalized Medicine 12:2, pages 163-175.
Crossref
Crossref
F. Rodieux, P. Berney, J. Desmeules & M. Besson. (2013) Douleur chronique : rôle de la pharmacogénétique dans la résistance aux antidépresseursChronic pain: role of pharmacogenetics in antidepressant treatment failure. Douleur et Analgésie 26:4, pages 218-225.
Crossref
Crossref
E Real, M Gratacòs, J Labad, P Alonso, G Escaramís, C Segalàs, M Subirà, C López-Solà, X Estivill & J M Menchón. (2012) Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive–compulsive disorder. The Pharmacogenomics Journal 13:5, pages 470-475.
Crossref
Crossref
Peter Höfer, Alexandra Schosser, Raffaella Calati, Alessandro Serretti, Isabelle Massat, Neslihan Aygun Kocabas, Anastasios Konstantinidis, Sylvie Linotte, Julien Mendlewicz, Daniel Souery, Joseph Zohar, Alzbeta Juven-Wetzler, Stuart Montgomery & Siegfried Kasper. (2012) The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk—a European multicentre study on treatment-resistant major depressive disorder. European Archives of Psychiatry and Clinical Neuroscience 263:5, pages 385-391.
Crossref
Crossref
Diane B. Miller & James P. O'Callaghan. (2013) Personalized medicine in major depressive disorder — Opportunities and pitfalls. Metabolism 62, pages S34-S39.
Crossref
Crossref
Irina Piatkov, Trudi Jones & Mark McLean. (2012) Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics. Journal of Personalized Medicine 2:4, pages 149-157.
Crossref
Crossref
Amitava Dasgupta. 2012. Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring. Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring
385
409
.
Alexandra Schosser, Alessandro Serretti, Daniel Souery, Julien Mendlewicz, Joseph Zohar, Stuart Montgomery & Siegfried Kasper. (2012) European Group for the Study of Resistant Depression (GSRD) — Where have we gone so far: Review of clinical and genetic findings. European Neuropsychopharmacology 22:7, pages 453-468.
Crossref
Crossref
Christine L. H. Snozek, Loralie J. Langman & Amitava Dasgupta. 2012. Pharmacogenomics in Clinical Therapeutics. Pharmacogenomics in Clinical Therapeutics
15
25
.
Sunita M. StewartAlex SimmonsEhsan Habibpour. (2012) Treatment of Culturally Diverse Children and Adolescents with Depression. Journal of Child and Adolescent Psychopharmacology 22:1, pages 72-79.
Crossref
Crossref
Hsien-Yuan Lane, Guochuan E. Tsai & Eugene Lin. (2012) Assessing Gene-Gene Interactions in Pharmacogenomics. Molecular Diagnosis & Therapy 16:1, pages 15-27.
Crossref
Crossref
Xiaohua Li, Mark A Frye & Richard C Shelton. (2011) Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development. Neuropsychopharmacology 37:1, pages 77-101.
Crossref
Crossref
Falk W. Lohoff. 2012. Principles of Psychiatric Genetics. Principles of Psychiatric Genetics
53
68
.
Leanne M Williams, A John Rush, Stephen H Koslow, Stephen R Wisniewski, Nicholas J Cooper, Charles B Nemeroff, Alan F Schatzberg & Evian Gordon. (2011) International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials 12:1.
Crossref
Crossref
Hueman Jaimes-Díaz, Adda Jeanette García-Chéquer, Alfonso Méndez-Tenorio, Juan Carlos Santiago-Hernández, Rogelio Maldonado-Rodríguez & Kenneth Loren Beattie. (2011) Bacterial classification using genomic fingerprints obtained by virtual hybridization. Journal of Microbiological Methods 87:3, pages 286-294.
Crossref
Crossref
Roseanne R. Krauter & Sarah S. Cook. (2011) Pharmacogenetics and the pharmacological management of depression. The Nurse Practitioner 36:10, pages 14-21.
Crossref
Crossref
Greta Wozniak, Aikaterini Toska, Maria Saridi & Odysseas Mouzas. (2011) Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis. Medical Science Monitor 17:9, pages RA205-RA214.
Crossref
Crossref
Maria Razzoli, Lucia Carboni, Michela Andreoli, Francesca Michielin, Alice Ballottari & Roberto Arban. (2011) Strain-specific outcomes of repeated social defeat and chronic fluoxetine treatment in the mouse. Pharmacology Biochemistry and Behavior 97:3, pages 566-576.
Crossref
Crossref
Nita A. Limdi & David L. Veenstra. (2010) Expectations, validity, and reality in pharmacogenetics. Journal of Clinical Epidemiology 63:9, pages 960-969.
Crossref
Crossref
Olga Kotsovolou, Magnus Ingelman-Sundberg, Matti A. Lang, Marios Marselos, David H. Overstreet, Zoi Papadopoulou-Daifoti, Inger Johanson, Andrew Fotopoulos & Maria Konstandi. (2010) Hepatic drug metabolizing profile of Flinders Sensitive Line rat model of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34:6, pages 1075-1084.
Crossref
Crossref
Lipa Cicin-Sain & Branimir Jernej. 2010. Experimental Models in Serotonin Transporter Research. Experimental Models in Serotonin Transporter Research
214
243
.
Wei ZhangM Eileen Dolan. (2010) Impact of the 1000 Genomes Project on the next wave of pharmacogenomic discovery. Pharmacogenomics 11:2, pages 249-256.
Crossref
Crossref
Sonja Horstmann, Susanne Lucae, Andreas Menke, Johannes M Hennings, Marcus Ising, Darina Roeske, Bertram Müller-Myhsok, Florian Holsboer & Elisabeth B Binder. (2009) Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment. Neuropsychopharmacology 35:3, pages 727-740.
Crossref
Crossref
Brigitta Bondy. 2010. Essentials of Genomic and Personalized Medicine. Essentials of Genomic and Personalized Medicine
722
730
.
Paul J. Jannetto. 2010. Molecular Diagnostics. Molecular Diagnostics
421
432
.
Nicole M. Walley, Paola Nicoletti & David B. Goldstein. 2010. Vogel and Motulsky's Human Genetics. Vogel and Motulsky's Human Genetics
635
647
.
Ning Wang, Dennis Drotar & Gurjit K. Khurana Hershey. 2010. Handbook of Genomics and the Family. Handbook of Genomics and the Family
437
456
.
Hadar Shalev & Jonathan Cohen. 2009. Stress ‐ From Molecules to Behavior. Stress ‐ From Molecules to Behavior
317
330
.
Eva Real, Mònica Gratacòs, Virginia Soria, Geòrgia Escaramís, Pino Alonso, Cinto Segalàs, Mònica Bayés, Rafael de Cid, José M. Menchón & Xavier Estivill. (2009) A Brain-Derived Neurotrophic Factor Haplotype Is Associated with Therapeutic Response in Obsessive-Compulsive Disorder. Biological Psychiatry 66:7, pages 674-680.
Crossref
Crossref
Svetlana OestergaardClaus Møldrup. (2009) Application of pharmacogenomics to clinical problems in depression. Personalized Medicine 6:5, pages 501-515.
Crossref
Crossref
Alessandro Serretti, Raffaella Calati, Isabelle Massat, Sylvie Linotte, Siegfried Kasper, Yves Lecrubier, Roser Sens-Espel, Joseph Bollen, Joseph Zohar, Jacques Berlo, Patricia Lienard, Diana De Ronchi, Julien Mendlewicz & Daniel Souery. (2009) Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients. International Clinical Psychopharmacology 24:5, pages 250-256.
Crossref
Crossref
Michael A. Nitsche, Min-Fang Kuo, Ralf Karrasch, Bettina Wächter, David Liebetanz & Walter Paulus. (2009) Serotonin Affects Transcranial Direct Current–Induced Neuroplasticity in Humans. Biological Psychiatry 66:5, pages 503-508.
Crossref
Crossref
Cristina Lanni, Stefano Govoni, Adele Lucchelli & Cinzia Boselli. (2009) Depression and antidepressants: molecular and cellular aspects. Cellular and Molecular Life Sciences 66:18, pages 2985-3008.
Crossref
Crossref
Edmond Chiu, David Ames, Brian Draper & John Snowdon. 2009. Depressive Disorders. Depressive Disorders
197
257
.
Cynthia A. ProwsTodd G. NickShannon N. SaldañaSanjeev PathakChunyan LiuKejian ZhangZachary S. DanielsAlexander A. VinksTracy A. Glauser. (2009) Drug-Metabolizing Enzyme Genotypes and Aggressive Behavior Treatment Response in Hospitalized Pediatric Psychiatric Patients. Journal of Child and Adolescent Psychopharmacology 19:4, pages 385-394.
Crossref
Crossref
Bárbara Arias, Alessandro Serretti, Laura Mandelli, Cristóbal Gastó, Rosa Catalán, Diana De Ronchi & Lourdes Fañanás. (2009) Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors. Pharmacogenetics and Genomics 19:2, pages 121-128.
Crossref
Crossref
Alessandro Bartolomucci & Rosario Leopardi. (2009) Stress and Depression: Preclinical Research and Clinical Implications. PLoS ONE 4:1, pages e4265.
Crossref
Crossref
Johannes M. Hennings, Toshimi Owashi, Elisabeth B. Binder, Sonja Horstmann, Andreas Menke, Stefan Kloiber, Tatjana Dose, Bastian Wollweber, Derek Spieler, Thomas Messer, Rita Lutz, Heike Künzel, Thomas Bierner, Thomas Pollmächer, Hildegard Pfister, Thomas Nickel, Annette Sonntag, Manfred Uhr, Marcus Ising, Florian Holsboer & Susanne Lucae. (2009) Clinical characteristics and treatment outcome in a representative sample of depressed inpatients – Findings from the Munich Antidepressant Response Signature (MARS) project. Journal of Psychiatric Research 43:3, pages 215-229.
Crossref
Crossref
Brigitta Bondy. 2009. Genomic and Personalized Medicine. Genomic and Personalized Medicine
1289
1298
.
Andrew H. Kemp, Evian Gordon, A. John Rush & Leanne M. Williams. (2014)
Improving the Prediction of Treatment Response in Depression:
Integration of Clinical, Cognitive, Psychophysiological, Neuroimaging, and Genetic Measures
. CNS Spectrums 13:12, pages 1066-1086.
Crossref
Crossref
Dennis L. Murphy, Meredith A. Fox, Kiara R. Timpano, Pablo R. Moya, Renee Ren-Patterson, Anne M. Andrews, Andrew Holmes, Klaus-Peter Lesch & Jens R. Wendland. (2008) How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology 55:6, pages 932-960.
Crossref
Crossref
Magnus Lekman, Silvia Paddock & Francis J. McMahon. (2012) Pharmacogenetics of Major Depression. Molecular Diagnosis & Therapy 12:5, pages 321-330.
Crossref
Crossref
M. J. Arranz & S. Kapur. (2008) Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?. Schizophrenia Bulletin 34:6, pages 1130-1144.
Crossref
Crossref
IB ChaudhryK. Neelam, V. Duddu & N. Husain. (2008) Ethnicity and psychopharmacology. Journal of Psychopharmacology 22:6, pages 673-680.
Crossref
Crossref
Florian Holsboer. (2008) How can we realize the promise of personalized antidepressant medicines?. Nature Reviews Neuroscience 9:8, pages 638-646.
Crossref
Crossref
Falk W. Lohoff. (2008) Pharmacogenetics of Major Depressive Disorder. Psychiatric Annals 38:6.
Crossref
Crossref
Brooke H Miller, Laura E Schultz, Anisha Gulati, Michael D Cameron & Mathew T Pletcher. (2007) Genetic Regulation of Behavioral and Neuronal Responses to Fluoxetine. Neuropsychopharmacology 33:6, pages 1312-1322.
Crossref
Crossref
N B Henrikson, W Burke & D L Veenstra. (2007) Ancillary risk information and pharmacogenetic tests: social and policy implications. The Pharmacogenomics Journal 8:2, pages 85-89.
Crossref
Crossref
Timothy Lambert & Trevor R. Norman. 2009. Ethno-psychopharmacology. Ethno-psychopharmacology
38
61
.
Wolfgang Maier & Astrid Zobel. (2008) Contribution of allelic variations to the phenotype of response to antidepressants and antipsychotics. European Archives of Psychiatry and Clinical Neuroscience 258:S1, pages 12-20.
Crossref
Crossref
Keizo Yoshida, Hisashi Higuchi, Hitoshi Takahashi, Mitsuhiro Kamata, Kazuhiro Sato, Kazuyuki Inoue, Toshio Suzuki, Kunihiko Itoh & Norio Ozaki. (2007)
Influence of the tyrosine hydroxylase val81met polymorphism and catechol‐
O
‐methyltransferase val158met polymorphism on the antidepressant effect of milnacipran
. Human Psychopharmacology: Clinical and Experimental 23:2, pages 121-128.
Crossref
Crossref
Brian Draper & Karen Berman. (2008) Tolerability of Selective Serotonin Reuptake Inhibitors. Drugs & Aging 25:6, pages 501-519.
Crossref
Crossref
Enrico Domenici, Pierandrea Muglia & Emilio Merlo-Pich. 2009. Biomarkers for Psychiatric Disorders. Biomarkers for Psychiatric Disorders
405
426
.
A. Serretti, A. Drago & Michael N Liebman. 2009. Biomarkers for Psychiatric Disorders. Biomarkers for Psychiatric Disorders
315
353
.
Ajit K. Parhi, Julie L. Wang, Shunichi Oya, Seok-Rye Choi, Mei-Ping Kung & Hank F. Kung. (2007) 2-(2′-((Dimethylamino)methyl)-4′-(fluoroalkoxy)-phenylthio)benzenamine Derivatives as Serotonin Transporter Imaging Agents. Journal of Medicinal Chemistry 50:26, pages 6673-6684.
Crossref
Crossref
Gonzalo Laje & Francis J. McMahon. (2007) The Pharmacogenetics of Major Depression: Past, Present, and Future. Biological Psychiatry 62:11, pages 1205-1207.
Crossref
Crossref
John P. Houston, David H. Adams, Sandra C. Kirkwood, Mark Farmen, AnnCatherine M. Downing & Alan Breier. (2007) Neuroreceptor Gene Polymorphisms and Olanzapine Depressive Symptom Response in Schizophrenia. Journal of Clinical Psychopharmacology 27:5, pages 520-523.
Crossref
Crossref
Gwenn S Smith, Faith M Gunning-Dixon, Francis E Lotrich, Warren D Taylor & Jovier D Evans. (2007) Translational Research in Late-Life Mood Disorders: Implications for Future Intervention and Prevention Research. Neuropsychopharmacology 32:9, pages 1857-1875.
Crossref
Crossref
Maria J. Arranz, Robert W. Kerwin & Janet C. Munro. 2007. Neurogenetics of Psychiatric Disorders. Neurogenetics of Psychiatric Disorders
173
194
.
R.A.S. ARIËNS. (2007) Getting to grips with complexity of disease will make genomics useful in arterial thrombosis. Journal of Thrombosis and Haemostasis 5:3, pages 450-453.
Crossref
Crossref
Peter A G M De Smet, Wilma Denneboom, Cees Kramers & Richard Grol. (2007) A Composite Screening Tool for Medication Reviews of Outpatients. Drugs & Aging 24:9, pages 733-760.
Crossref
Crossref
Daniel W. Nebert & Elliot S. Vesell. (2006) Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics. Trends in Pharmacological Sciences 27:11, pages 580-586.
Crossref
Crossref